antimutagenic agents

Preferred Label : antimutagenic agents;

MeSH definition : Agents that reduce the frequency or rate of spontaneous or induced mutations independently of the mechanism involved.;

MeSH synonym : agents, anti-mutagenic; agents, antimutagenic; anti-mutagenic agents; anti mutagenic agents; antimutagens; Antimutagen; Anti-Mutagenic Agent; Agent, Anti-Mutagenic; Anti Mutagenic Agent; Antimutagenic Agent; Agent, Antimutagenic;

Related MeSH term : antimutagenic effect; Effect, Antimutagenic; Anti-Mutagenic Effects; Anti Mutagenic Effects; Effects, Anti-Mutagenic; Antimutagenic Effects; Effects, Antimutagenic; Anti-Mutagenic Effect; Anti Mutagenic Effect; Effect, Anti-Mutagenic;

MeSH annotation : note entry term ANTIMUTAGENIC EFFECT: use only for the antimutagenic effect of a chemical substance;

Wikipedia link : https://en.wikipedia.org/wiki/Antimutagenic agents;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D016587;

UMLS CUI

C0085168;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
Indexing information
- 8-oxodGTPase [MeSH Supplementary Concept]
- glucoputranjivin [MeSH Supplementary Concept]
- isopropyl isothiocyanate [MeSH Supplementary Concept]
- larifan [MeSH Supplementary Concept]
Record concept(s)
- antimutagenic agents [MeSH concept]
- antimutagenic effect [MeSH concept]
See also
- anticarcinogenic agents [MeSH Descriptor]
- mutagenesis [MeSH Descriptor]
- mutation [MeSH Descriptor]
Semantic type(s)
- Chemical Viewed Functionally [UMLS semantic type]
Substance(s)
- 5,6-diacetoxy1-benzoyloxymethyl-1,3-cyclohexadiene [MeSH Supplementary Concept]
- 6-O-palmitoylascorbic acid [MeSH Supplementary Concept]
- Resveratrol [MeSH Descriptor]
- caffeine, sodium benzoate drug combination [MeSH Supplementary Concept]
- chlorophyllin [MeSH Supplementary Concept]
- cinnamaldehyde [MeSH Supplementary Concept]
- cobaltous chloride [MeSH Supplementary Concept]
- diallyl disulfide [MeSH Supplementary Concept]
- dicarbine [MeSH Supplementary Concept]
- epigallocatechin gallate [MeSH Supplementary Concept]
- germanium oxide [MeSH Supplementary Concept]
- polymethyl methacrylate [MeSH Descriptor]
- vanillin [MeSH Supplementary Concept]
- xymedon [MeSH Supplementary Concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients